These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 35125878)

  • 1. Acylcarnitines: Can They Be Biomarkers of Diabetic Nephropathy?
    Mu X; Yang M; Ling P; Wu A; Zhou H; Jiang J
    Diabetes Metab Syndr Obes; 2022; 15():247-256. PubMed ID: 35125878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of early circulating biomolecules associated with diabetes nephropathy - Ideal candidates for early biomarker array test for DN.
    Quan KY; Yap CG; Jahan NK; Pillai N
    Diabetes Res Clin Pract; 2021 Dec; 182():109122. PubMed ID: 34742785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the use of biomarkers of diabetic nephropathy.
    Jha JC; Jandeleit-Dahm KA; Cooper ME
    Adv Chronic Kidney Dis; 2014 May; 21(3):318-26. PubMed ID: 24780461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive metabolic signatures for the occurrence and development of diabetic nephropathy and the intervention of Ginkgo biloba leaves extract based on gas or liquid chromatography with mass spectrometry.
    Du Y; Xu BJ; Deng X; Wu XW; Li YJ; Wang SR; Wang YN; Ji S; Guo MZ; Yang DZ; Tang DQ
    J Pharm Biomed Anal; 2019 Mar; 166():30-39. PubMed ID: 30599279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomics in diabetic nephropathy: Unveiling novel biomarkers for diagnosis (Review).
    Luo Y; Zhang W; Qin G
    Mol Med Rep; 2024 Sep; 30(3):. PubMed ID: 38963028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary Biomarkers in the Assessment of Early Diabetic Nephropathy.
    Gluhovschi C; Gluhovschi G; Petrica L; Timar R; Velciov S; Ionita I; Kaycsa A; Timar B
    J Diabetes Res; 2016; 2016():4626125. PubMed ID: 27413755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation between cognitive impairment and diabetic nephropathy in patients with Type 2 diabetes mellitus].
    Shi X; Zhang Y; Niu H; Wang R; Shen J; Zhou S; Yang H; Wang S; Wu J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 41(2):143-50. PubMed ID: 26932211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of two novel renal tubular proteins in type 2 diabetic patients with nephropathy.
    Abdel Ghafar MT; Shalaby KH; Okda HI; Abo El Gheit RE; Soliman NA; Keshk WA
    J Investig Med; 2020 Mar; 68(3):748-755. PubMed ID: 31722957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [What values should be used to diagnose microalbuminuria in patients with diabetes mellitus?].
    Leitão CB; Canani LH; Bolson PB; Molon MP; Silveiro SP; Gross JL
    Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):322-6. PubMed ID: 16767298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of novel biomarkers in predicting diabetic nephropathy: a review.
    Uwaezuoke SN
    Int J Nephrol Renovasc Dis; 2017; 10():221-231. PubMed ID: 28860837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of circulating lncRNA expression profiles in patients with diabetes mellitus and diabetic nephropathy: Differential expression profile of circulating lncRNA
.
    Yang Y; Lv X; Fan Q; Wang X; Xu L; Lu X; Chen T
    Clin Nephrol; 2019 Jul; 92(1):25-35. PubMed ID: 31079598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy.
    Campion CG; Sanchez-Ferras O; Batchu SN
    Can J Kidney Health Dis; 2017; 4():2054358117705371. PubMed ID: 28616250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted metabolomics as a tool for the diagnosis of kidney disease in Type II diabetes mellitus.
    Abdelsattar S; Kasemy ZA; Elsayed M; Elrahem TA; Zewain SK
    Br J Biomed Sci; 2021 Oct; 78(4):184-190. PubMed ID: 33656967
    [No Abstract]   [Full Text] [Related]  

  • 15. Genomics, Proteomics and Metabolomics Approaches for Predicting Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients.
    Darmayanti S; Lesmana R; Meiliana A; Abdulah R
    Curr Diabetes Rev; 2021; 17(6):e123120189796. PubMed ID: 33393899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary Cyclophilin A and serum Cystatin C as biomarkers for diabetic nephropathy in children with type 1 diabetes.
    Salem NA; El Helaly RM; Ali IM; Ebrahim HAA; Alayooti MM; El Domiaty HA; Aboelenin HM
    Pediatr Diabetes; 2020 Aug; 21(5):846-855. PubMed ID: 32304131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
    Shoukry A; Bdeer Sel-A; El-Sokkary RH
    Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic nephropathy: traditional to proteomic markers.
    Moresco RN; Sangoi MB; De Carvalho JA; Tatsch E; Bochi GV
    Clin Chim Acta; 2013 Jun; 421():17-30. PubMed ID: 23485645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary Excretion of Kidney Aquaporins as Possible Diagnostic Biomarker of Diabetic Nephropathy.
    Rossi L; Nicoletti MC; Carmosino M; Mastrofrancesco L; Di Franco A; Indrio F; Lella R; Laviola L; Giorgino F; Svelto M; Gesualdo L; Procino G
    J Diabetes Res; 2017; 2017():4360357. PubMed ID: 28246612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of diabetic nephropathy in older patients with diabetes mellitus type 2].
    Karić E; Tulumović D; Ramić E; Zildzić M; Tulumović A
    Med Arh; 2008; 62(5-6):261-3. PubMed ID: 19469265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.